Additionally, the sterol-binding protein SREBP-1, a transcription factor regulating lipid homeostasis, was upregulated in NAFLD rats and its physiological level was restored by the nutraceutical formulation (Figure 9D). Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.